U.S. to spend more than $2 billion to launch Biden’s biomanufacturing initiative
The federal government is pledging more than $2 billion to launch President Biden’s new national biomanufacturing initiative, funding efforts to build or expand drug manufacturing sites in the U.S. and readying the raw materials needed to respond to a new pandemic.
Related Knowledge Center: Biotechnology: overview
Roundup of developments in biotechnology industries and policymaking.